Covalon Technologies Ltd. (COV)
TSX Venture Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 4.130 |
|---|---|
| 52-week range | 1.550 – 4.590 |
| Return, 1 month / 3 months | +1.7% / +89.4% |
| Return, 1 year / 3 years | +102.1% / +207.3% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 57.4% |
| Worst drawdown (1 year) | -27.8% |
| Average daily value traded | 0.10M CAD |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Covalon Technologies Ltd. is a medical technology company that develops and makes products for wound care and infection prevention. Its offerings include silicone-based wound dressings, antimicrobial coatings for medical devices, and related products used in hospitals and other healthcare settings. The company is based in Mississauga, Ontario, Canada, and serves healthcare providers and medical device makers.
The shares are listed on the TSX Venture Exchange in Canada under the code COV, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Covalon Technologies Ltd. (COV) trades on the TSX Venture Exchange in Canada. It last closed at CAD 4.130 on 23 October 2026.
Its price-based Market X-Ray is 84 out of 100 (a strong price profile), ranking 34 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 102.1% and over the last three months it rose 89.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 96 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 77.9% | ||
| From 52-week high | -9.4% | ||
| Momentum | 94 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 89.5% | ||
| 6-month return | 117.4% | ||
| 12-month return, skipping the last month | 98.6% | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.8% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 0.10M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 19 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | +1.7% |
| 3 months | +89.4% |
| 6 months | +117.4% |
| 1 year | +102.1% |
| 3 years | +207.3% |
| 5 years | +73.5% |
Signals
| 50-day / 200-day average | 3.465 / 2.322 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.235 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Nov 2025 | CAD 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.